Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

about

The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis

P2860

Q57107650-9725BC97-B3C5-4E6C-9B86-976881C20165

P2860

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

Item

http://www.wikidata.org/entity/Q41283989

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Circulating tumor cells correl ...... one-sensitive prostate cancer.

@en

type

Item

label

Circulating tumor cells correl ...... one-sensitive prostate cancer.

@en

prefLabel

Circulating tumor cells correl ...... one-sensitive prostate cancer.

@en

P1476

Circulating tumor cells correl ...... mone-sensitive prostate cancer

@en

P2093

Alberto Bonetta

http://www.w3.org/2001/XMLSchema#string

Daniele Generali

http://www.w3.org/2001/XMLSchema#string

Maria Rosa Cappelletti

http://www.w3.org/2001/XMLSchema#string

Silvia Paola Corona

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Guideline for the management of clinically localized prostate cancer: 2007 update.

Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer

Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy.

Predicting the risk of bone metastasis in prostate cancer.

PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials.

Clinical Utility of Circulating Tumor Cells in Advanced Prostate Cancer.

Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel.

P304

3811-3815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S143020

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giandomenico Roviello

P577

2017-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28814879

http://www.w3.org/2001/XMLSchema#string

P932

5546825

http://www.w3.org/2001/XMLSchema#string

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

about

P2860

P2860

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932